Genitourinary Cancer,Prostate Cancer ARASENS Study Evaluated Darolutamide Combo for mHSPC Jul 17, 2023
Genitourinary Cancer,Prostate Cancer Cabozantinib Plus Atezolizumab in mCRCPC: Results From COSMIC-021 Trial Jun 30, 2023
Genitourinary Cancer,Prostate Cancer Bone Biomarkers and Survival in Hormone-Sensitive Prostate Cancer Jun 08, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Pembrolizumab Plus Lenvatinib as First-Line Treatment for nCRCC Jun 02, 2023
Genitourinary Cancer,Prostate Cancer Nivolumab Plus Docetaxel in Chemotherapy-Naïve mCRPC: CheckMate 9KD Trial Results Jun 01, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Cabozantinib Plus Nivolumab Shows Promise in Non-clear-Cell Renal Cell Carcinoma May 30, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) CTX130: A Promising Treatment Option for Relapsed or Refractory Renal Cell Carcinoma in COBALT-RCC Study May 30, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Concurrent and Adjuvant Durvalumab With Chemoradiotherapy in Advanced Cervical Cancer May 22, 2023
